What is US Specialty Formulations?
US Specialty Formulations (USSF) operates as a cGMP-compliant Contract Development and Manufacturing Organization (CDMO) based in Allentown, PA. The company is dedicated to providing high-quality pharmaceutical formulation services, with a specialization in the development of complex pharmaceutical products. This includes custom formulations, vaccines, and botanical extracts, serving a clientele of pharmaceutical production companies and healthcare professionals. USSF's expertise in formulation, regulatory compliance, and advanced manufacturing is crucial for supporting new drug inventors and diagnostic developers in bringing their innovations to market. Their commitment to quality and innovation aims to advance global healthcare through reliable clinical materials and tailored solutions.
How much funding has US Specialty Formulations raised?
US Specialty Formulations has raised a total of $2.8M across 1 funding round:
Debt
$2.8M
Debt (2024): $2.8M, investors not publicly disclosed
What's next for US Specialty Formulations?
The recent major strategic investment signifies a pivotal moment for US Specialty Formulations, likely enabling the company to scale its manufacturing capabilities, enhance its research and development initiatives, and potentially expand its service offerings. This infusion of capital is expected to accelerate its mission to support the pharmaceutical industry in bringing complex and vital products to market, reinforcing its role as a key CDMO in the pharmaceutical supply chain. The enterprise-level nature of the funding suggests a focus on long-term strategic growth and market expansion.
See full US Specialty Formulations company page
